News & Events
News
ACTIV-2/A5401 Study Results
Identifying characteristics associated with SARS-CoV-2 RNA shedding may be useful to understand viral compartmentalization, disease pathogenesis, and risks for viral transmission. In this study, SARS-CoV-2 RNA shedding was concordant across compartments. Age was strongly associated with viral shedding and men had slower viral clearance than women, which could explain sex differences in acute COVID-19 outcomes.
Four UCLA Health physicians elected to Association of American Physicians
April 11, 2022
Four UCLA physicians have been elected to the Association of American Physicians...
Updated Efficacy, Safety, and Case Studies in HPTN 083
February 16, 2022
In a large clinical trial assessing Apretude, ViiV Healthcare’s recently approved injectable drug, as a...
Long-Acting Injectable PrEP for HIV Risk
October 03, 2021
Long-acting pre-exposure prophylaxis (PrEP) is not only a long sought-after...
July 30, 2021
“Weight gain and the chronic conditions to which...
Four Potential COVID-19 Therapeutics Enter Phase 2/3 Testing in NIH ACTIV-2 Trial
February 12, 2021
Enrollment has begun to test additional investigational drugs in the...
FDA approves 1st long-acting HIV drug combo, monthly shots
January 21, 2021
…“Even people who are taking one pill once a day just reported...
Ride Health and ACTIV-2 Partner to Provide Transportation for Nationwide COVID-19 Therapeutic Study
January 05, 2021
…“As we designed the ACTIV-2 protocol, it became clear that we would need to..
NIH re-funds ACTG for the next seven years
November 30, 2020
…“The ACTG is honored to have the continued support of the NIH, which will allow us to continue...
November 16, 2020
…“The ACTG has long been committed to improving..."
UCLA begins recruitment for phase 3 of The Oxford University - AstraZeneca COVID-19 Vaccine Trial
October 29, 2020
…“The safety of our volunteers and participants is the first priority of...
UCLA draws record $1.4 billion in research funding
October 12, 2020
UCLA attracted record support for its wide-ranging research in the...
BTAN Empowers the Black Community Through Education
May 01, 2012
Empowering the Black Community: Education as a Foundation for Reducing Health Disparities.
October 10, 2022
Since the onset of the COVID-19 pandemic, Dr. Kara Chew, a clinical investigator at the UCLA Center for Clinical AIDS Research and Education (CARE) ...
Injected PrEP: cabotegravir maintains its advantage over four years
February 18, 2022
An update on HPTN 083, the study that established that PrEP given as an injection every two months...
Watch In The Know: A community webinar highlighting new insights in HIV and COVID research
December 08, 2021
In The Know A community webinar highlighting...
Bimonthly, Injected PrEP Beats Daily Pill in Warding Off HIV: Study
August 12, 2021
When the antiretroviral regimen known as pre-exposure prophylaxis, or PrEP, was launched nearly...
Top 5 stories on injectable HIV treatment and prevention from CROI 2021
March 23, 2021
Dr. Raphael Landovitz presented findings on injectable PrEP to CROI 2021...
Months after fighting coronavirus, some now face heart, lung or neurological problems
February 06, 2021
…“COVID-19 is a disease of extremes. Some people can be asymptomatic and
Meet two doctors fighting for BIPOC representation in clinical trials
January 18, 2021
…How are communities of color disproportionately impacted by the...
January 05, 2021
Read what UCLA Health infectious disease experts, including Drs. Judith Currier and...
AstraZeneca Trial Volunteer Faces Fear, Hopes to Help End Pandemic
November 26, 2020
…“I think we’ve all felt so helpless," said Dr. Landovitz.
The latest on AstraZeneca’s COVID-19 vaccine development
November 12, 2020
Listen to Dr. Raphael Landovitz, lead vaccine researcher for the...
UCLA Researchers Testing Effectiveness Of COVID Plasma Transfusions
October 16, 2020
Watch Dr. Currier discuss the plasma antibody trial for people...
Dan Savage Interviews Dr. Raphael Landovitz About Injectable PrEP
October 06, 2020
On Savage Lovecast episode #728, hear Dan Savage interview Dr. Raphael Landovitz about the promise of a new
Events
Men's Health Fair
Friday, June 10, 2022, 9am - 2pm. MLK Jr. Outpatient Center, 1670 E. 120th St., Los Angeles, CA 90059. Free Activities Will Include: Health screenings, Live DJ, Information from licensed healthcare providers, Community resources, In-N-Out Burger*, Free haircuts*, Free swag bags, Fun raffles! Ask about recruiter enrollment!!!
*First come, first serve for tested individuals only. Must be 13 years or older.
For more information about this event, call 323-563-5802 or IG CDU.DrewCares
Decade of HIV CARE: An HIV/AIDS 40-year retrospective virtual event
May 24, 2021
June 5, 2021 marks the 40th anniversary of the first description of Pneumocystis pneumonia in the setting of what we know as AIDS in 5 patients in Los Angeles – in the Centers for Disease Control’s Morbidity and Mortality Weekly Report (MMWR).These observations, by Dr. Michael Gottlieb, from UCLA, and Dr. Joel Weisman began to define the challenges that would shape the research and treatment agendas of the subsequent 40 years of a global pandemic.
18th Annual HIV CME Symposium Tough Decisions Made Easier - Archived
September 09, 2021
The UCLA Center for Clinical AIDS Research & Education (CARE), UCLA Pacific AIDS Education Training Center (PAETC), UCLA AIDS Institute, and Center for HIV Identification, Prevention and Treatment Services (CHIPTS) proudly present the 18th Annual HIV CME Symposium "Tough Decisions Made Easier: Clinical Management of Treatment - Experienced Patients."
Bridging the Gap: HIV research experience for COVID solutions
Tuesday, November 10th, 2020.
6:00 PM-8:00 PM
Join UCLA Health for a pop-up drive-in event to learn how the knowledge and capacity already developed by researchers at the CARE Center are accelerating the development of new tools to fight COVID-19 and current state/future of treatment and prevention studies.